Table 1.
Correlation between SNHG15 expression and EOC clinicopathological features
| Parameters | No of patients (n=182) | SNHG15 high/low (73/109) | P-value |
|---|---|---|---|
|
| |||
| Age | 0.977 | ||
| <60 years | 85 | 34/51 | |
| ≥60 years | 97 | 39/58 | |
| CA125 | 0.081 | ||
| <500 U/mL | 104 | 36/68 | |
| ≥500 U/mL | 78 | 37/41 | |
| Cancer type | 0.001 | ||
| Type I | 94 | 27/67 | |
| Type II | 88 | 46/42 | |
| Ascites | 0.043 | ||
| <100 mL | 111 | 38/73 | |
| ≥100 mL | 71 | 35/36 | |
| FIGO stage | 0.049 | ||
| I/II | 41 | 11/30 | |
| III/IV | 141 | 62/79 | |
Abbreviations: EOC, epithelial ovarian cancer; FIGO, International Federation of Gynaecology and Obstetrics.